TY - STD TI - Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumoniaAm J Respir Crit Care Med 2005,171(4):388–416. ID - ref1 ER - TY - JOUR AU - Vincent, J. L. AU - Bihari, D. J. AU - Suter, P. M. AU - Bruining, H. A. AU - White, J. AU - Nicolas- Chanoin, M. H. PY - 1995 DA - 1995// TI - The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study JO - Journal of the American Medical Association VL - 274 UR - https://doi.org/10.1001/jama.1995.03530080055041 DO - 10.1001/jama.1995.03530080055041 ID - Vincent1995 ER - TY - JOUR AU - Grupper, M. AU - Kravtsov, A. AU - Potasman, I. PY - 2009 DA - 2009// TI - Enterococcal-associated lower respiratory tract infections: a case report and literature review JO - Infection VL - 37 UR - https://doi.org/10.1007/s15010-007-7123-7 DO - 10.1007/s15010-007-7123-7 ID - Grupper2009 ER - TY - JOUR AU - Gastmeier, P. AU - Sohr, D. AU - Geffers, C. AU - Ruden, H. AU - Vonberg, R. P. AU - Welte, T. PY - 2009 DA - 2009// TI - Early- and late-onset pneumonia: is this still a useful classification? JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.01070-08 DO - 10.1128/AAC.01070-08 ID - Gastmeier2009 ER - TY - JOUR AU - Bloos, F. AU - Hinder, F. AU - Becker, K. AU - Sachse, S. AU - Mekontso Dessap, A. AU - Straube, E. PY - 2010 DA - 2010// TI - A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis JO - Intensive Care Med VL - 36 UR - https://doi.org/10.1007/s00134-009-1705-z DO - 10.1007/s00134-009-1705-z ID - Bloos2010 ER - TY - JOUR AU - Alberti, C. AU - Brun-Buisson, C. AU - Chevret, S. AU - Antonelli, M. AU - Goodman, S. V. AU - Martin, C. PY - 2005 DA - 2005// TI - Systemic inflammatory response and progression to severe sepsis in critically ill infected patients JO - Am J Respir Crit Care Med VL - 171 UR - https://doi.org/10.1164/rccm.200403-324OC DO - 10.1164/rccm.200403-324OC ID - Alberti2005 ER - TY - JOUR AU - Valles, J. AU - Rello, J. AU - Ochagavia, A. AU - Garnacho, J. AU - Alcala, M. A. PY - 2003 DA - 2003// TI - Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival JO - Chest VL - 123 UR - https://doi.org/10.1378/chest.123.5.1615 DO - 10.1378/chest.123.5.1615 ID - Valles2003 ER - TY - JOUR AU - Kollef, M. H. AU - Sherman, G. AU - Ward, S. AU - Fraser, V. J. PY - 1999 DA - 1999// TI - Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically III patients JO - Chest VL - 115 UR - https://doi.org/10.1378/chest.115.2.462 DO - 10.1378/chest.115.2.462 ID - Kollef1999 ER - TY - JOUR AU - Luna, C. M. AU - Vujacich, P. AU - Niederman, M. S. AU - Vay, C. AU - Gherardi, C. AU - Matera, J. PY - 1997 DA - 1997// TI - Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia JO - Chest VL - 111 UR - https://doi.org/10.1378/chest.111.3.676 DO - 10.1378/chest.111.3.676 ID - Luna1997 ER - TY - JOUR AU - Iregui, M. AU - Ward, S. AU - Sherman, G. AU - Fraser, V. J. AU - Kollef, M. H. PY - 2002 DA - 2002// TI - Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia JO - Chest VL - 122 UR - https://doi.org/10.1378/chest.122.1.262 DO - 10.1378/chest.122.1.262 ID - Iregui2002 ER - TY - JOUR AU - Kumar, A. AU - Haery, C. AU - Paladugu, B. AU - Symeoneides, S. AU - Taiberg, L. AU - Osman, J. PY - 2006 DA - 2006// TI - The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels JO - J Infect Dis VL - 193 UR - https://doi.org/10.1086/498909 DO - 10.1086/498909 ID - Kumar2006 ER - TY - JOUR AU - Shorr, A. F. AU - Micek, S. T. AU - Kollef, M. H. PY - 2008 DA - 2008// TI - Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications JO - Critical Care Medicine VL - 36 UR - https://doi.org/10.1097/CCM.0b013e31818103ea DO - 10.1097/CCM.0b013e31818103ea ID - Shorr2008 ER - TY - JOUR AU - Kumar, A. AU - Ellis, P. AU - Arabi, Y. AU - Roberts, D. AU - Light, B. AU - Parrillo, J. E. PY - 2009 DA - 2009// TI - Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock JO - Chest VL - 136 ID - Kumar2009 ER - TY - JOUR AU - Kollef, M. H. AU - Shorr, A. AU - Tabak, Y. P. AU - Gupta, V. AU - Liu, L. Z. AU - Johannes, R. S. PY - 2005 DA - 2005// TI - Epidemiology and outcomes of health-care-associated pneumonia: Results from a large US database of culture-positive pneumonia JO - Chest VL - 128 UR - https://doi.org/10.1378/chest.128.6.3854 DO - 10.1378/chest.128.6.3854 ID - Kollef2005 ER - TY - JOUR AU - Klein, E. AU - Smith, D. L. AU - Laxminarayan, R. PY - 2007 DA - 2007// TI - Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005 JO - Emerging Infectious Diseases VL - 13 UR - https://doi.org/10.3201/eid1312.070629 DO - 10.3201/eid1312.070629 ID - Klein2007 ER - TY - JOUR AU - Klevens, R. M. AU - Edwards, J. R. AU - Tenover, F. C. AU - McDonald, L. C. AU - Horan, T. AU - Gaynes, R. PY - 2006 DA - 2006// TI - Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003 JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/499367 DO - 10.1086/499367 ID - Klevens2006 ER - TY - JOUR AU - Hidron, A. I. AU - Low, C. E. AU - Honig, E. G. AU - Blumberg, H. M. PY - 2009 DA - 2009// TI - Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia JO - The Lancet Infectious Diseases VL - 9 UR - https://doi.org/10.1016/S1473-3099(09)70133-1 DO - 10.1016/S1473-3099(09)70133-1 ID - Hidron2009 ER - TY - JOUR AU - Rybak, M. AU - Lomaestro, B. AU - Rotschafer, J. C. AU - Moellering, R. AU - Craig, W. AU - Billeter, M. PY - 2009 DA - 2009// TI - Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists JO - American Journal of Health-System Pharmacy VL - 66 UR - https://doi.org/10.2146/ajhp080434 DO - 10.2146/ajhp080434 ID - Rybak2009 ER - TY - JOUR AU - Chang, S. AU - Sievert, D. M. AU - Hageman, J. C. AU - Boulton, M. L. AU - Ten-over, F. C. AU - Downes, F. P. PY - 2003 DA - 2003// TI - Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene JO - The New England journal of medicine VL - 348 UR - https://doi.org/10.1056/NEJMoa025025 DO - 10.1056/NEJMoa025025 ID - Chang2003 ER - TY - JOUR AU - Steinkraus, G. AU - White, R. AU - Friedrich, L. PY - 2007 DA - 2007// TI - Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05 JO - The Journal of antimicrobial chemotherapy VL - 60 UR - https://doi.org/10.1093/jac/dkm258 DO - 10.1093/jac/dkm258 ID - Steinkraus2007 ER - TY - JOUR AU - Wang, G. AU - Hindler, J. F. AU - Ward, K. W. AU - Bruckner, D. A. PY - 2006 DA - 2006// TI - Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period JO - Journal of clinical microbiology VL - 44 UR - https://doi.org/10.1128/JCM.01388-06 DO - 10.1128/JCM.01388-06 ID - Wang2006 ER - TY - JOUR AU - Rybak, M. J. AU - Lomaestro, B. M. AU - Rotschafer, J. C. AU - Moellering, R. C. AU - Craig, W. A. AU - Billeter, M. PY - 2009 DA - 2009// TI - Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists JO - Clin Infect Dis VL - 49 UR - https://doi.org/10.1086/600877 DO - 10.1086/600877 ID - Rybak2009 ER - TY - JOUR AU - Welte, T. AU - Pletz, M. W. PY - 2010 DA - 2010// TI - Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options JO - Int J Antimicrob Agents VL - 36 UR - https://doi.org/10.1016/j.ijantimicag.2010.06.045 DO - 10.1016/j.ijantimicag.2010.06.045 ID - Welte2010 ER - TY - JOUR AU - Georges, H. AU - Leroy, O. AU - Alfandari, S. AU - Guery, B. AU - Roussel-Delvallez, M. AU - Dhennain, C. PY - 1997 DA - 1997// TI - Pulmonary disposition of vancomycin in critically ill patients JO - Eur J Clin Microbiol Infect Dis VL - 16 UR - https://doi.org/10.1007/BF01726369 DO - 10.1007/BF01726369 ID - Georges1997 ER - TY - JOUR AU - Cruciani, M. AU - Gatti, G. AU - Lazzarini, L. AU - Furlan, G. AU - Broccali, G. AU - Malena, M. PY - 1996 DA - 1996// TI - Penetration of vancomycin into human lung tissue JO - The Journal of antimicrobial chemotherapy VL - 38 UR - https://doi.org/10.1093/jac/38.5.865 DO - 10.1093/jac/38.5.865 ID - Cruciani1996 ER - TY - JOUR AU - González, C. AU - Rubio, M. AU - Romero-Vivas, J. AU - González, M. AU - Picazo, J. J. PY - 1999 DA - 1999// TI - Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms JO - Clin Infect Dis VL - 29 UR - https://doi.org/10.1086/313440 DO - 10.1086/313440 ID - González1999 ER - TY - JOUR AU - Scheetz, M. H. AU - Wunderink, R. G. AU - Postelnick, M. J. AU - Noskin, G. A. PY - 2006 DA - 2006// TI - Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia JO - Pharmacotherapy VL - 26 UR - https://doi.org/10.1592/phco.26.4.539 DO - 10.1592/phco.26.4.539 ID - Scheetz2006 ER - TY - JOUR AU - Flandrois, J. P. AU - Fardel, G. AU - Carret, G. PY - 1988 DA - 1988// TI - Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 32 UR - https://doi.org/10.1128/AAC.32.4.454 DO - 10.1128/AAC.32.4.454 ID - Flandrois1988 ER - TY - JOUR AU - Levine, D. P. PY - 2006 DA - 2006// TI - Vancomycin: a history JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/491709 DO - 10.1086/491709 ID - Levine2006 ER - TY - JOUR AU - Kielstein, J. T. AU - Kretschmer, U. AU - Ernst, T. AU - Hafer, C. AU - Bahr, M. J. AU - Haller, H. PY - 2004 DA - 2004// TI - Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study JO - Am J Kidney Dis VL - 43 UR - https://doi.org/10.1053/j.ajkd.2003.10.021 DO - 10.1053/j.ajkd.2003.10.021 ID - Kielstein2004 ER - TY - JOUR AU - Metnitz, P. G. AU - Krenn, C. G. AU - Steltzer, H. AU - Lang, T. AU - Ploder, J. AU - Lenz, K. PY - 2002 DA - 2002// TI - Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients JO - Critical care medicine VL - 30 UR - https://doi.org/10.1097/00003246-200209000-00016 DO - 10.1097/00003246-200209000-00016 ID - Metnitz2002 ER - TY - JOUR AU - Sesso, R. AU - Roque, A. AU - Vicioso, B. AU - Stella, S. PY - 2004 DA - 2004// TI - Prognosis of ARF in hospitalized elderly patients JO - Am J Kidney Dis VL - 44 UR - https://doi.org/10.1016/S0272-6386(04)00811-X DO - 10.1016/S0272-6386(04)00811-X ID - Sesso2004 ER - TY - JOUR AU - Vinsonneau, C. AU - Camus, C. AU - Combes, A. AU - Costa de Beauregard, M. A. AU - Klouche, K. AU - Boulain, T. PY - 2006 DA - 2006// TI - Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69111-3 DO - 10.1016/S0140-6736(06)69111-3 ID - Vinsonneau2006 ER - TY - JOUR AU - Palmer, S. M. AU - Rybak, M. J. PY - 1996 DA - 1996// TI - Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots JO - Antimicrob Agents Chemother VL - 40 ID - Palmer1996 ER - TY - JOUR AU - Varaldo, P. E. AU - Debbia, E. AU - Schito, G. C. PY - 1983 DA - 1983// TI - In vitro activity of teichomycin and vancomycin alone and in combination with rifampin JO - Antimicrob Agents Chemother VL - 23 UR - https://doi.org/10.1128/AAC.23.3.402 DO - 10.1128/AAC.23.3.402 ID - Varaldo1983 ER - TY - JOUR AU - Faville, R. J. AU - Zaske, D. E. AU - Kaplan, E. L. AU - Crossley, K. AU - Sabath, L. D. AU - Quie, P. G. PY - 1978 DA - 1978// TI - Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin JO - JAMA VL - 240 UR - https://doi.org/10.1001/jama.1978.03290180037019 DO - 10.1001/jama.1978.03290180037019 ID - Faville1978 ER - TY - JOUR AU - Jung, Y. J. AU - Koh, Y. AU - Hong, S. B. AU - Chung, J. W. AU - Choi, S. H. AU - Kim, N. J. PY - 2010 DA - 2010// TI - Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia JO - Critical Care Medicine VL - 38 UR - https://doi.org/10.1097/CCM.0b013e3181b9ecea DO - 10.1097/CCM.0b013e3181b9ecea ID - Jung2010 ER - TY - JOUR AU - Jung, Y. J. AU - Koh, Y. AU - Hong, S. B. AU - Chung, J. W. AU - Ho Choi, S. AU - Kim, N. J. PY - 2010 DA - 2010// TI - Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia JO - Crit Care Med VL - 38 UR - https://doi.org/10.1097/CCM.0b013e3181b9ecea DO - 10.1097/CCM.0b013e3181b9ecea ID - Jung2010 ER - TY - JOUR AU - Marchese, A. AU - Schito, G. C. PY - 2001 DA - 2001// TI - The oxazolidinones as a new family of antimicrobial agent JO - Clinical Microbiology and Infection VL - 7 UR - https://doi.org/10.1046/j.1469-0691.2001.00060.x DO - 10.1046/j.1469-0691.2001.00060.x ID - Marchese2001 ER - TY - JOUR AU - Burkhardt, O. AU - Pletz, M. W. AU - Mertgen, C. P. AU - Welte, T. PY - 2007 DA - 2007// TI - Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia JO - Recent Pat Antiinfect Drug Discov VL - 2 UR - https://doi.org/10.2174/157489107780832659 DO - 10.2174/157489107780832659 ID - Burkhardt2007 ER - TY - JOUR AU - Craig, W. A. PY - 2003 DA - 2003// TI - Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid JO - Infect Dis Clin North Am VL - 17 UR - https://doi.org/10.1016/S0891-5520(03)00065-5 DO - 10.1016/S0891-5520(03)00065-5 ID - Craig2003 ER - TY - JOUR AU - Andes, D. AU - van Ogtrop, M. L. AU - Peng, J. AU - Craig, W. A. PY - 2002 DA - 2002// TI - In vivo pharmacodynamics of a new oxazolidinone (linezolid) JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.11.3484-3489.2002 DO - 10.1128/AAC.46.11.3484-3489.2002 ID - Andes2002 ER - TY - STD TI - Zyvox [package insert] New York, NY: Pfizer, Inc; 2008. ID - ref43 ER - TY - JOUR AU - Conte, J. E. AU - Golden, J. A. AU - Kipps, J. AU - Zurlinden, E. PY - 2002 DA - 2002// TI - Intrapulmonary pharmacokinetics of linezolid JO - Antimicrobial Agents and Chemotherapy VL - 46 UR - https://doi.org/10.1128/AAC.46.5.1475-1480.2002 DO - 10.1128/AAC.46.5.1475-1480.2002 ID - Conte2002 ER - TY - JOUR AU - Stalker, D. J. AU - Jungbluth, G. L. PY - 2003 DA - 2003// TI - Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial JO - Clinical Pharmacokinetics VL - 42 UR - https://doi.org/10.2165/00003088-200342130-00004 DO - 10.2165/00003088-200342130-00004 ID - Stalker2003 ER - TY - JOUR AU - Burkhardt, O. AU - Borner, K. AU - von der Hoh, N. AU - Koppe, P. AU - Pletz, M. W. AU - Nord, C. E. PY - 2002 DA - 2002// TI - Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers JO - J Antimicrob Chemother VL - 50 UR - https://doi.org/10.1093/jac/dkf163 DO - 10.1093/jac/dkf163 ID - Burkhardt2002 ER - TY - JOUR AU - Tsiodras, S. AU - Gold, H. S. AU - Sakoulas, G. AU - Eliopoulos, G. M. AU - Wennersten, C. AU - Venkataraman, L. PY - 2001 DA - 2001// TI - Linezolid resistance in a clinical isolate of Staphylococcus aureus JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)05410-1 DO - 10.1016/S0140-6736(01)05410-1 ID - Tsiodras2001 ER - TY - JOUR AU - Jones, R. N. AU - Fritsche, T. R. AU - Sader, H. S. AU - Ross, J. E. PY - 2007 DA - 2007// TI - LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers) JO - Diagnostic microbiology and infectious disease VL - 59 UR - https://doi.org/10.1016/j.diagmicrobio.2007.06.004 DO - 10.1016/j.diagmicrobio.2007.06.004 ID - Jones2007 ER - TY - JOUR AU - Attassi, K. AU - Hershberger, E. AU - Alam, R. AU - Zervos, M. J. PY - 2002 DA - 2002// TI - Thrombocytopenia associated with linezolid therapy JO - Clin Infect Dis VL - 34 UR - https://doi.org/10.1086/338403 DO - 10.1086/338403 ID - Attassi2002 ER - TY - JOUR AU - Bishop, E. AU - Melvani, S. AU - Howden, B. P. AU - Charles, P. G. AU - Grayson, M. L. PY - 2006 DA - 2006// TI - Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients JO - Antimicrobial agents and chemotherapy VL - 50 UR - https://doi.org/10.1128/AAC.50.4.1599-1602.2006 DO - 10.1128/AAC.50.4.1599-1602.2006 ID - Bishop2006 ER - TY - JOUR AU - Orrick, J. J. AU - Johns, T. AU - Janelle, J. AU - Ramphal, R. PY - 2002 DA - 2002// TI - Thrombocytopenia secondary to linezolid administration: what is the risk? JO - Clin Infect Dis VL - 35 UR - https://doi.org/10.1086/341310 DO - 10.1086/341310 ID - Orrick2002 ER - TY - JOUR AU - Lin, Y. H. AU - Wu, V. C. AU - Tsai, I. J. AU - Ho, Y. L. AU - Hwang, J. J. AU - Tsau, Y. K. PY - 2006 DA - 2006// TI - High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency JO - International journal of antimicrobial agents VL - 28 UR - https://doi.org/10.1016/j.ijantimicag.2006.04.017 DO - 10.1016/j.ijantimicag.2006.04.017 ID - Lin2006 ER - TY - JOUR AU - De Vriese, A. S. AU - Coster, R. V. AU - Smet, J. AU - Seneca, S. AU - Lovering, A. AU - Van Haute, L. L. PY - 2006 DA - 2006// TI - Linezolid-induced inhibition of mitochondrial protein synthesis JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/501356 DO - 10.1086/501356 ID - De Vriese2006 ER - TY - JOUR AU - Azamfirei, L. AU - Copotoiu, S. M. AU - Branzaniuc, K. AU - Szederjesi, J. AU - Copotoiu, R. AU - Berteanu, C. PY - 2007 DA - 2007// TI - Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy JO - Pharmacoepidemiology and drug safety VL - 16 UR - https://doi.org/10.1002/pds.1320 DO - 10.1002/pds.1320 ID - Azamfirei2007 ER - TY - JOUR AU - Lawrence, K. R. AU - Adra, M. AU - Gillman, P. K. PY - 2006 DA - 2006// TI - Serotonin toxicity associated with the use of linezolid: a review of post-marketing data JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/503839 DO - 10.1086/503839 ID - Lawrence2006 ER - TY - JOUR AU - Kollef, M. H. AU - Rello, J. AU - Cammarata, S. K. AU - Croos-Dabrera, R. V. AU - Wunderink, R. G. PY - 2004 DA - 2004// TI - Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin JO - Intensive Care Med VL - 30 UR - https://doi.org/10.1007/s00134-003-2088-1 DO - 10.1007/s00134-003-2088-1 ID - Kollef2004 ER - TY - JOUR AU - Wunderink, R. G. AU - Rello, J. AU - Cammarata, S. K. AU - Croos-Dabrera, R. V. AU - Kollef, M. H. PY - 2003 DA - 2003// TI - Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia JO - Chest VL - 124 ID - Wunderink2003 ER - TY - JOUR AU - Rubinstein, E. AU - Cammarata, S. AU - Oliphant, T. AU - Wunderink, R. PY - 2001 DA - 2001// TI - Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study JO - Clin Infect Dis VL - 32 UR - https://doi.org/10.1086/318486 DO - 10.1086/318486 ID - Rubinstein2001 ER - TY - JOUR AU - Wunderink, R. G. AU - Cammarata, S. K. AU - Oliphant, T. H. AU - Kollef, M. H. PY - 2003 DA - 2003// TI - Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia JO - Clin Ther VL - 25 UR - https://doi.org/10.1016/S0149-2918(03)80118-2 DO - 10.1016/S0149-2918(03)80118-2 ID - Wunderink2003 ER - TY - JOUR AU - Conte, J. E. AU - Golden, J. A. AU - Kipps, J. AU - Zurlinden, E. PY - 2002 DA - 2002// TI - Intrapulmonary pharmacokinetics of linezolid JO - Antimicrobial agents and chemotherapy VL - 46 UR - https://doi.org/10.1128/AAC.46.5.1475-1480.2002 DO - 10.1128/AAC.46.5.1475-1480.2002 ID - Conte2002 ER - TY - JOUR AU - Powers, J. H. AU - Lin, D. AU - Ross, D. PY - 2005 DA - 2005// TI - FDA evaluation of antimicrobials: subgroup analysis JO - Chest VL - 127 UR - https://doi.org/10.1378/chest.127.6.2298 DO - 10.1378/chest.127.6.2298 ID - Powers2005 ER - TY - JOUR AU - Powers, J. H. AU - Ross, D. B. AU - Lin, D. AU - Soreth, J. PY - 2004 DA - 2004// TI - Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses JO - Chest VL - 126 UR - https://doi.org/10.1378/chest.126.1.314 DO - 10.1378/chest.126.1.314 ID - Powers2004 ER - TY - JOUR AU - Wunderink, R. G. AU - Mendelson, M. H. AU - Somero, M. S. AU - Fabian, T. C. AU - May, A. K. AU - Bhattacharyya, H. PY - 2008 DA - 2008// TI - Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus JO - Chest VL - 134 UR - https://doi.org/10.1378/chest.08-0011 DO - 10.1378/chest.08-0011 ID - Wunderink2008 ER - TY - JOUR AU - Kalil, A. C. AU - Murthy, M. H. AU - Hermsen, E. D. AU - Neto, F. K. AU - Sun, J. AU - Rupp, M. E. PY - 2010 DA - 2010// TI - Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis JO - Crit Care Med VL - 38 UR - https://doi.org/10.1097/CCM.0b013e3181eb3b96 DO - 10.1097/CCM.0b013e3181eb3b96 ID - Kalil2010 ER - TY - JOUR AU - Beibei, L. AU - Yun, C. AU - Mengli, C. AU - Nan, B. AU - Xuhong, Y. AU - Rui, W. PY - 2010 DA - 2010// TI - Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials JO - Int J Antimicrob Agents VL - 35 UR - https://doi.org/10.1016/j.ijantimicag.2009.09.013 DO - 10.1016/j.ijantimicag.2009.09.013 ID - Beibei2010 ER - TY - JOUR AU - Reinhart, K. AU - Brunkhorst, F. M. AU - Bone, H. G. AU - Bardutzky, J. AU - Dempfle, C. E. AU - Forst, H. PY - 2010 DA - 2010// TI - Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)) JO - Ger Med Sci VL - 8 ID - Reinhart2010 ER - TY - JOUR AU - Chang, F. Y. AU - Peacock, J. E. AU - Musher, D. M. AU - Triplett, P. AU - MacDonald, B. B. AU - Mylotte, J. M. PY - 2003 DA - 2003// TI - Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study JO - Medicine VL - 82 UR - https://doi.org/10.1097/01.md.0000091184.93122.09 DO - 10.1097/01.md.0000091184.93122.09 ID - Chang2003 ER - TY - JOUR AU - Lodise, T. P. AU - McKinnon, P. S. AU - Levine, D. P. AU - Rybak, M. J. PY - 2007 DA - 2007// TI - Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus JO - Antimicrobial agents and chemotherapy VL - 51 UR - https://doi.org/10.1128/AAC.00101-07 DO - 10.1128/AAC.00101-07 ID - Lodise2007 ER - TY - JOUR AU - Tice, A. D. AU - Hoaglund, P. A. AU - Shoultz, D. A. PY - 2003 DA - 2003// TI - Risk factors and treatment outcomes in osteomyelitis JO - The Journal of antimicrobial chemotherapy VL - 51 UR - https://doi.org/10.1093/jac/dkg186 DO - 10.1093/jac/dkg186 ID - Tice2003 ER - TY - JOUR AU - Silverman, J. A. AU - Mortin, L. I. AU - VanPraagh, A. D. G. AU - Li, T. AU - Alder, J. PY - 2005 DA - 2005// TI - Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact JO - Journal of Infectious Diseases VL - 191 UR - https://doi.org/10.1086/430352 DO - 10.1086/430352 ID - Silverman2005 ER - TY - JOUR AU - Henken, S. AU - Bohling, J. AU - Martens-Lobenhoffer, J. AU - Paton, J. C. AU - Ogunniyi, A. D. AU - Briles, D. E. PY - 2010 DA - 2010// TI - Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00943-09 DO - 10.1128/AAC.00943-09 ID - Henken2010 ER - TY - JOUR AU - Freire, A. T. AU - Melnyk, V. AU - Kim, M. J. AU - Datsenko, O. AU - Dzyublik, O. AU - Glumcher, F. PY - 2010 DA - 2010// TI - Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia JO - Diagn Microbiol Infect Dis VL - 68 UR - https://doi.org/10.1016/j.diagmicrobio.2010.05.012 DO - 10.1016/j.diagmicrobio.2010.05.012 ID - Freire2010 ER - TY - STD TI - Synercid [package insert] Bristol, TN: Monarch Pharmaceuticals, Inc and Greenville, NC: DSM Pharmaceuticals, Inc; 2003. ID - ref73 ER - TY - JOUR PY - 2005 DA - 2005// TI - Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia JO - American journal of respiratory and critical care medicine VL - 171 UR - https://doi.org/10.1164/rccm.200405-644ST DO - 10.1164/rccm.200405-644ST ID - ref74 ER - TY - JOUR AU - Fagon, J. Y. AU - Patrick, H. AU - Haas, D. W. AU - Torres, A. AU - Gibert, C. AU - Cheadle, W. G. PY - 2000 DA - 2000// TI - Treatment of Gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group JO - American journal of respiratory and critical care medicine VL - 161 UR - https://doi.org/10.1164/ajrccm.161.3.9904115 DO - 10.1164/ajrccm.161.3.9904115 ID - Fagon2000 ER -